Roots-Analysis-Logo.png
The pharmaceutical contract research services market, is anticipated to be worth USD 59 billion by 2030, growing at an annualized rate of over 10%, claims Roots Analysis
13 sept. 2021 08h25 HE | Roots Analysis
London, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Pharmaceutical Contract Research Services Market, 2021-2030” report to its list of offerings. Majority of...
Roots-Analysis-Logo.png
The peptide therapeutics market is projected to be worth around USD 41.7 Billion in 2030, claims Roots Analysis
09 sept. 2021 08h36 HE | Roots Analysis
London, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Peptide Therapeutics Market, 2021 – 2030” report to its list of offerings. Characterized by a rapidly...
Decibel-full color-CMYK.png
Decibel Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss
09 sept. 2021 07h30 HE | Decibel Therapeutics, Inc.
BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore...
Roots-Analysis-Logo.png
The CRISPR based therapeutics market is projected to be worth around USD 2.2 billion by 2030, growing at an annualized rate of 129.2%, claims Roots Analysis
03 août 2021 08h31 HE | Roots Analysis
London, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “CRISPR based Therapeutics Market, 2021-2030” report to its list of offerings. With over 115 candidates under...
Roots-Analysis-Logo.png
The polycystic ovary syndrome market is anticipated to be worth USD 5 billion by 2031 growing at an annualized rate of 4%, claims Roots Analysis
21 juil. 2021 08h30 HE | Roots Analysis
London, July 21, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Polycystic Ovary Syndrome Market, 2021-2031” report to its list of offerings. Currently, there is no cure...
Roots-Analysis-Logo.png
The opportunity within the display library technologies and services market is projected to be USD 382 million by 2030, claims Roots Analysis
20 juil. 2021 08h00 HE | Roots Analysis
London, July 20, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Display Library Technologies and Affiliated Services Market, 2021-2030” report to its list of offerings. ...
Roots-Analysis-Logo.png
The TCR-based therapies market is projected to be worth around USD 4.4 billion, by 2030, claims Roots Analysis
15 juil. 2021 08h45 HE | Roots Analysis
London, July 15, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “TCR-based Therapies Market, 2021-2030” report to its list of offerings. Modified TCR-based adoptive T-cell...
Roots-Analysis-Logo.png
The viral and non-viral vector manufacturing market is projected to grow at an annualized rate of over 15%, claims Roots Analysis
06 mai 2021 08h45 HE | Roots Analysis
London, May 06, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th Edition) 2021 – 2030” report to its...
Roots-Analysis-Logo.png
The gene therapy market is projected to be worth USD 14.6 billion in 2030, growing at a CAGR of 30%, over the next decade, claims Roots Analysis
02 févr. 2021 11h19 HE | Roots Analysis
London, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Gene Therapy Market (4th Edition), 2020-2030” report to its list of offerings. Success of approved gene...
Reports and Data.jpeg-01
Regenerative Medicine Market Size Worth $23.57 Bn By 2027; High demand for 3D bioprinting of tissues and organs to better understand their mechanism is driving revenue growth of this segment currently | Reports and Data
18 janv. 2021 08h51 HE | Reports and Data
New York, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Increased investment in advanced technologies for treatment of genetic and chronic diseases is driving growth of the regenerative medicine market. Market...